NM_000127.3:c.1284+25G>A
Variant names:
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2
The NM_000127.3(EXT1):c.1284+25G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000663 in 1,613,570 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 0.00013 ( 0 hom., cov: 31)
Exomes 𝑓: 0.000060 ( 1 hom. )
Consequence
EXT1
NM_000127.3 intron
NM_000127.3 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.0900
Genes affected
EXT1 (HGNC:3512): (exostosin glycosyltransferase 1) This gene encodes an endoplasmic reticulum-resident type II transmembrane glycosyltransferase involved in the chain elongation step of heparan sulfate biosynthesis. Mutations in this gene cause the type I form of multiple exostoses. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.81).
BP6
Variant 8-117830205-C-T is Benign according to our data. Variant chr8-117830205-C-T is described in ClinVar as [Likely_benign]. Clinvar id is 255171.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population amr. gnomad4 allele frequency = 0.000131 (20/152206) while in subpopulation AMR AF= 0.00085 (13/15286). AF 95% confidence interval is 0.000503. There are 0 homozygotes in gnomad4. There are 11 alleles in male gnomad4 subpopulation. Median coverage is 31. This position pass quality control queck.
BS2
High AC in GnomAd4 at 20 AD gene.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
EXT1 | ENST00000378204.7 | c.1284+25G>A | intron_variant | Intron 4 of 10 | 1 | NM_000127.3 | ENSP00000367446.3 | |||
EXT1 | ENST00000436216.2 | n.*85+25G>A | intron_variant | Intron 5 of 5 | 3 | ENSP00000400372.1 | ||||
EXT1 | ENST00000437196.1 | n.*175+25G>A | intron_variant | Intron 3 of 9 | 5 | ENSP00000407299.1 | ||||
EXT1 | ENST00000684189.1 | n.751+25G>A | intron_variant | Intron 4 of 10 |
Frequencies
GnomAD3 genomes AF: 0.000132 AC: 20AN: 152088Hom.: 0 Cov.: 31
GnomAD3 genomes
AF:
AC:
20
AN:
152088
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000128 AC: 32AN: 250942Hom.: 1 AF XY: 0.000155 AC XY: 21AN XY: 135646
GnomAD3 exomes
AF:
AC:
32
AN:
250942
Hom.:
AF XY:
AC XY:
21
AN XY:
135646
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000595 AC: 87AN: 1461364Hom.: 1 Cov.: 31 AF XY: 0.0000729 AC XY: 53AN XY: 727000
GnomAD4 exome
AF:
AC:
87
AN:
1461364
Hom.:
Cov.:
31
AF XY:
AC XY:
53
AN XY:
727000
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000131 AC: 20AN: 152206Hom.: 0 Cov.: 31 AF XY: 0.000148 AC XY: 11AN XY: 74404
GnomAD4 genome
AF:
AC:
20
AN:
152206
Hom.:
Cov.:
31
AF XY:
AC XY:
11
AN XY:
74404
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Likely benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not specified Benign:1
-
PreventionGenetics, part of Exact Sciences
Significance: Likely benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing
- -
Exostoses, multiple, type 1 Benign:1
Jul 07, 2023
KCCC/NGS Laboratory, Kuwait Cancer Control Center
Significance: Likely benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
RBP_binding_hub_radar
RBP_regulation_power_radar
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at